Giulia Toti

Giulia Toti leads Ankar’s life sciences go-to-market and strategic partnerships, shaping how the company collaborates with global pharma, biotech, and medtech organizations. She also oversees product strategy for the sector, driving how Ankar’s technology supports innovation and growth across the life sciences ecosystem.

Giulia began her career in immuno-oncology R&D at GSK and later joined AstraZeneca’s Global Strategy and Insights team. She subsequently advised leading pharmaceutical, medtech, and diagnostics clients on growth, M&A, and commercialization strategies as part of L.E.K. Consulting’s life sciences practice. Before joining Ankar, she was an investor at Montagu Private Equity, where she focused on scaling innovative healthcare, data, and digital health platforms.